Last week Alabama reached settlements with three pharmaceutical companies whom it had accused of fueling the opioid addiction crisis. Drug distributor McKeeson Corp. will pay the state $141 million. Johnson & Johnson will pay $70.3 million. Endo will hand over a relatively modest $25 million.
Those moneys will go toward the state’s efforts to combat opioid addiction. Separately, the companies will also pay a total of $40 million toward the state’s attorneys’ fees.
J&J, which was responsible for the pain medications Duragesic and Nucynta, says that it no longer sells prescription opioids in the United States. It denies wrongdoing as to its past marketing efforts.